1–10 of 100 results for Proliferative Diabetic Retinopathy
Shooting Stars
Majda Hadziahmetovic, MD
Retina Image Bank: Images of the Week
2025
Intraoperative Fluorescein Angiography Reduces the Rate of Postoperative Vitreous Hemorrhage
Alan J. Franklin, MD, PhD
Annual Meeting Talks
2024
Dropless Vitrectomy Surgery for Dense Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy; Efficacy and Safety Compared With Standard of Care
K. V. Chalam, MD, PhD, MBA, FRCS(C), FASRS
Aurora Borealis in Retina
Poornachandra B, MS, FVRS
Naresh Kumar Yadav, FRCS
Postoperative Methotrexate Reduces Reoperations and Improves Vision After Vitrectomy for Proliferative Diabetic Retinopathy
Updates from the Field
Association Between DRSS Changes and Visual/ Anatomic Outcomes in Patients With Moderately Severe to Severe NPDR: Post Hoc Analysis of PANORAMA
Diana V Do, MD, FASRS
2022
New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Bobeck S Modjtahedi, MD
Intravitreal Methotrexate Reduces Reoperation Rate and Improves Vision After Vitrectomy for Retinal Detachment, Trauma, and Proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Aditya S Kelkar, MS, FRCS, FASRS,FRCOphth
High risk Proliferative Diabetic Retinopathy treated with Pan Retinal Photocoagulation
Somnath Chakraborty, MD